-
Something wrong with this record ?
Ethambutol-induced optic neuropathy
M. Kyncl, M. Fus, J. Lestak
Language English Country Czech Republic
Document type Case Reports
NLK
Directory of Open Access Journals
from 2001
Free Medical Journals
from 1998
Medline Complete (EBSCOhost)
from 2007-06-01
ROAD: Directory of Open Access Scholarly Resources
from 2001
PubMed
35582729
DOI
10.5507/bp.2022.022
Knihovny.cz E-resources
- MeSH
- Antitubercular Agents adverse effects MeSH
- Adult MeSH
- Ethambutol adverse effects MeSH
- Humans MeSH
- Optic Nerve Diseases * chemically induced diagnosis pathology MeSH
- Optic Nerve diagnostic imaging pathology MeSH
- Tomography, Optical Coherence methods MeSH
- Tuberculosis * MeSH
- Check Tag
- Adult MeSH
- Humans MeSH
- Publication type
- Case Reports MeSH
PURPOSE: A case report of a 40-year-old patient with tuberculosis treated with ethambutol is described. Within six months of starting treatment, there was a painless sudden decline in visual function. Despite the known complications of ethambutol treatment, it was discontinued after another three months. METHODS: In the case report, we highlight the damage to the dominantly peripheral visual pathways. Using electrophysiological examinations, we showed a significant alteration in the optic nerves. Optical Coherence Tomography (OCT) showed progressive loss of vessel density and nerve fibre layer of retinal ganglion cells. Perimetric examination showed both a central decrease in sensitivity and mainly scotomas in the temporal parts of the visual fields. Although there was improvement in visual fields over time, OCT findings indicated progression of ethambutol-induced optic neuropathy (EON). Magnetic Resonance Imaging confirmed the alteration in the peripheral part of the visual pathway (intraorbital, intracranial parts of optic nerves, chiasma, and optic tracts). CONCLUSION: Even though EON is not an unknown complication, new cases still occur and, unfortunately, with an irreversible course. Therefore, it is important to draw attention constantly to this complication and to consider it not only in ophthalmologists' surgeries.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23018197
- 003
- CZ-PrNML
- 005
- 20231121092151.0
- 007
- ta
- 008
- 231107s2023 xr a f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.5507/bp.2022.022 $2 doi
- 035 __
- $a (PubMed)35582729
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Kyncl, Martin $u Faculty of Biomedical Engineering, Czech Technical University in Prague, Kladno
- 245 10
- $a Ethambutol-induced optic neuropathy / $c M. Kyncl, M. Fus, J. Lestak
- 520 9_
- $a PURPOSE: A case report of a 40-year-old patient with tuberculosis treated with ethambutol is described. Within six months of starting treatment, there was a painless sudden decline in visual function. Despite the known complications of ethambutol treatment, it was discontinued after another three months. METHODS: In the case report, we highlight the damage to the dominantly peripheral visual pathways. Using electrophysiological examinations, we showed a significant alteration in the optic nerves. Optical Coherence Tomography (OCT) showed progressive loss of vessel density and nerve fibre layer of retinal ganglion cells. Perimetric examination showed both a central decrease in sensitivity and mainly scotomas in the temporal parts of the visual fields. Although there was improvement in visual fields over time, OCT findings indicated progression of ethambutol-induced optic neuropathy (EON). Magnetic Resonance Imaging confirmed the alteration in the peripheral part of the visual pathway (intraorbital, intracranial parts of optic nerves, chiasma, and optic tracts). CONCLUSION: Even though EON is not an unknown complication, new cases still occur and, unfortunately, with an irreversible course. Therefore, it is important to draw attention constantly to this complication and to consider it not only in ophthalmologists' surgeries.
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a ethambutol $x škodlivé účinky $7 D004977
- 650 _2
- $a antituberkulotika $x škodlivé účinky $7 D000995
- 650 12
- $a nemoci zrakového nervu $x chemicky indukované $x diagnóza $x patologie $7 D009901
- 650 _2
- $a nervus opticus $x diagnostické zobrazování $x patologie $7 D009900
- 650 12
- $a tuberkulóza $7 D014376
- 650 _2
- $a optická koherentní tomografie $x metody $7 D041623
- 655 _2
- $a kazuistiky $7 D002363
- 700 1_
- $a Fůs, Martin $u Faculty of Biomedical Engineering, Czech Technical University in Prague, Kladno $7 xx0227865
- 700 1_
- $a Lešták, Ján, $u Faculty of Biomedical Engineering, Czech Technical University in Prague, Kladno $d 1955- $7 xx0057880
- 773 0_
- $w MED00012606 $t Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia $x 1804-7521 $g Roč. 167, č. 3 (2023), s. 288-293
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/35582729 $y Pubmed
- 910 __
- $a ABA008 $b A 1502 $c 958 $y p $z 0
- 990 __
- $a 20231107 $b ABA008
- 991 __
- $a 20231121092148 $b ABA008
- 999 __
- $a ok $b bmc $g 2011498 $s 1204600
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 167 $c 3 $d 288-293 $e 20220516 $i 1804-7521 $m Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $n Biomed. Pap. Fac. Med. Palacký Univ. Olomouc Czech Repub. (Print) $x MED00012606
- LZP __
- $b NLK198 $a Pubmed-20231107